|
AU2003223601A1
(en)
|
2002-04-12 |
2003-10-27 |
King's College London |
ANTI-INFLAMMATORY AND WOUND HEALING EFFECTS OF LYMPHOID THYMOSIN Beta 4
|
|
EP1536821A4
(en)
|
2002-06-17 |
2009-09-09 |
Wyeth Corp |
INHIBITION OF T CELL ACTIVATION BY BUTYROPHILIN A AND B7-L1
|
|
EP1702622A1
(en)
|
2005-03-18 |
2006-09-20 |
CONARIS research institute AG |
Soluble BTNL2 protein useful to inhibit inflammatory disorders
|
|
PT1999154E
(pt)
*
|
2006-03-24 |
2013-01-24 |
Merck Patent Gmbh |
Domínios proteicos heterodiméricos modificados
|
|
WO2008154516A2
(en)
|
2007-06-11 |
2008-12-18 |
The Board Of Regents, The Universtity Ot Texas System |
Btnl2 fusion protein for t-cell activity modulation
|
|
GB0717101D0
(en)
|
2007-09-03 |
2007-10-10 |
Cambridge Entpr Ltd |
Tumour marker
|
|
JP6157046B2
(ja)
*
|
2008-01-07 |
2017-07-05 |
アムジェン インコーポレイテッド |
静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法
|
|
US20130101590A1
(en)
|
2010-04-09 |
2013-04-25 |
Heather A. Arnett |
Btnl9 proteins, nucleic acids, and antibodies and uses thereof
|
|
KR101860963B1
(ko)
*
|
2010-04-23 |
2018-05-24 |
제넨테크, 인크. |
이종다량체 단백질의 생산
|
|
SG11201401422VA
(en)
*
|
2011-10-27 |
2014-09-26 |
Genmab As |
Production of heterodimeric proteins
|
|
WO2013098420A1
(en)
|
2011-12-28 |
2013-07-04 |
Immunoqure Ag |
Method of isolating human antibodies
|
|
US10131709B2
(en)
|
2011-12-28 |
2018-11-20 |
Immunoqure Ag |
Nucleic acid molecules encoding monoclonal antibodies specific for IL-22
|
|
EP2875046B2
(en)
|
2012-07-19 |
2025-04-30 |
Amgen Inc. |
Human btnl3 proteins, nucleic acids, and antibodies and uses thereof
|
|
WO2014106839A1
(en)
|
2013-01-01 |
2014-07-10 |
Kahr Medical Ltd. |
Stable form of signal converting protein fusion proteins, and methods of use and preparation thereof
|
|
GB201300049D0
(en)
|
2013-01-03 |
2013-02-20 |
Transimmune Ag |
Method for obtaining immuno-stimulatory dendritic cells
|
|
GB201300052D0
(en)
|
2013-01-03 |
2013-02-20 |
Transimmune Ag |
Method for obtaining immuno-suppressive dendritic cells
|
|
JP6742237B2
(ja)
|
2013-07-03 |
2020-08-19 |
イムノキュア アーゲーＩｍｍｕｎｏｑｕｒｅ Ａｇ |
ヒト抗ｉｆｎ−アルファ抗体
|
|
WO2015001047A1
(en)
|
2013-07-03 |
2015-01-08 |
Immunoqure Ag |
Method of providing anti-human cytokine antibodies for pharmaceutical use
|
|
AU2014286128B2
(en)
|
2013-07-03 |
2019-10-10 |
Immunoqure Ag |
Human anti-IL-32 antibodies
|
|
JP2016540046A
(ja)
|
2013-11-29 |
2016-12-22 |
シーエスエル、リミテッド |
ガンの治療方法
|
|
DK3129404T3
(da)
|
2014-04-10 |
2026-04-20 |
Lava Therapeutics N V |
Immunglobuliner, der binder humane vgamma9vdelta2-t-cellereceptorer
|
|
GB201413665D0
(en)
|
2014-07-03 |
2014-09-17 |
Transimmune Ag And Yale University |
Method for obtaining globally activated monocytes
|
|
WO2016085662A1
(en)
*
|
2014-11-25 |
2016-06-02 |
Albert Einstein College Of Medicine, Inc. |
Btnl9 and ermap as novel inhibitors of the immune system for immunotherapies
|
|
CN108064176A
(zh)
|
2015-04-22 |
2018-05-22 |
库瑞瓦格股份公司 |
用于治疗肿瘤疾病的含有rna的组合物
|
|
US20180147257A1
(en)
|
2015-05-22 |
2018-05-31 |
The Board Of Trustees Of The Leland Stanford Junior University |
Btn3a ectodomain proteins and methods of use
|
|
JP6981973B2
(ja)
*
|
2015-10-01 |
2021-12-17 |
ヒート バイオロジクス，インコーポレイテッド |
Ｉ型及びｉｉ型細胞外ドメインを異種キメラタンパク質として連結する組成物及び方法
|
|
WO2017072367A1
(en)
|
2015-10-30 |
2017-05-04 |
Cancer Research Technology Limited |
EXPANSION OF NON-HAEMATOPOIETIC TISSUE-RESIDENT γδ T CELLS AND USES OF THESE CELLS
|
|
EP3383911B1
(en)
|
2015-12-02 |
2021-01-20 |
STCube & Co. Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
|
GB201521389D0
(en)
*
|
2015-12-03 |
2016-01-20 |
Ucb Biopharma Sprl |
Method
|
|
CN116769054A
(zh)
*
|
2016-02-05 |
2023-09-19 |
奥里尼斯生物科学私人有限公司 |
双特异性信号传导剂及其用途
|
|
CN109071636A
(zh)
|
2016-03-29 |
2018-12-21 |
斯特库比股份有限公司 |
用于选择特异性结合糖基化免疫检查点蛋白的抗体的方法
|
|
WO2018082590A1
(zh)
*
|
2016-11-02 |
2018-05-11 |
北京蛋白质组研究中心 |
肿瘤免疫治疗靶标及其应用
|
|
WO2018201130A1
(en)
|
2017-04-28 |
2018-11-01 |
The Brigham And Women's Hospital, Inc. |
Targeting gamma-delta t cells in obesity and cachexia
|
|
CN111051346A
(zh)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
使用免疫特异性结合btn1a1的抗体和分子治疗癌症的方法
|
|
KR20200015602A
(ko)
|
2017-05-31 |
2020-02-12 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1에 면역특이적으로 결합하는 항체 및 분자 및 이의 치료적 용도
|
|
KR20200026209A
(ko)
|
2017-06-06 |
2020-03-10 |
주식회사 에스티큐브앤컴퍼니 |
Btn1a1 또는 btn1a1-리간드에 결합하는 항체 및 분자를 사용하여 암을 치료하는 방법
|
|
WO2018229163A1
(en)
|
2017-06-14 |
2018-12-20 |
King's College London |
Methods of activating v delta 2 negative gamma delta t cells
|
|
EP3681996B1
(en)
|
2017-09-15 |
2024-08-07 |
King's College London |
Compositions and methods for enhancing gamma delta t cells in the gut
|
|
KR102764182B1
(ko)
|
2017-09-21 |
2025-02-07 |
임체크 테라퓨틱스 |
Ｂｔｎ２에 대해 특이성을 갖는 항체 및 이의 용도
|
|
US11098093B2
(en)
*
|
2019-01-07 |
2021-08-24 |
Shattuck Labs, Inc. |
Heterodimeric proteins for modulating gamma delta T cells
|